Plant metabolic response to stress in an arid ecosystem is mediated by the presence of neighbors.

Plant neighbors in arid environments can ameliorate abiotic stress by reducing insolation, but they also attract herbivores and pathogens, especially when neighbors are close relatives that share similar antagonists. Plants' metabolic profiles provide a chemical fingerprint of the physiological processes behind plant responses to different environmental stresses. For example, abscisic acid and proline, mainly involved in stomatal closure and osmotic adjustment, can induce plant responses to abiotic stress, while jasmonic acid and salicylic acid primarily regulate plant defense to herbivory or pathogens. Neighbor plants can generate contrasting ecological contexts, modulating plant responses to abiotic and biotic stresses. We hypothesize that plant metabolic profile is modulated by its neighbors in a vegetation patch, expecting a higher investment in metabolites related to biotic-stress tolerance (i.e., herbivory or pathogens) when growing associated with other plants, especially to phylogenetically close relatives, compared to plants growing alone. We show that plants from five species growing with neighbors invest more in biotic-stress tolerance while their conspecifics, growing alone, invest more in abiotic-stress tolerance. This tendency in plants' metabolic profiles was not affected by the phylogenetic diversity of their neighborhood. Linking physiological snapshots with community processes can contribute to elucidating metabolic profiles derived from plant-plant interactions.

Mézières Method as a practice of embodiment in patients with low back pain: a mixed study.

INTRODUCTION: The objectives of this study were to determine the effects of the Mézières Method (MM) on pain and disability related to low back pain (LBP), compared to a program of heat, massage and exercise, and to understand the meaning of the bodily experience with the MM. PATIENTS AND METHODS: Mixed methods convergent parallel design, combining an equivalent randomized clinical trial with a qualitative phenomenological approach. Sixty-one participants aged 18-65 years with chronic non-specific LBP lasting more than 3 months. Patients were randomized into two groups: the MM group (n = 29) and the comparison group (CG) who received heat, massage plus flexibility and strengthening exercises (n = 31). MM and CG participants underwent 10 one-hour physical therapy sessions over a 5-week period and were evaluated three times: pre-intervention, post-intervention and follow-up at 6 weeks after the end of treatment. RESULTS: Both groups reported positive effects on LBP . MM group showed superior effects in pain relief in the short term (Cohen's D 0.80; p = 0.004). Participants interpreted the interaction with the MM as a teaching-learning process that allowed body awareness. CONCLUSION: Both treatment were similarly beneficial but MM had superior effects on pain in the short term. MM is perceived by the participants as a teaching-learning process focused on body awareness that facilitate effective management of LBP.

Phylogenetic and functional constraints of plant facilitation rewiring.

Facilitative interactions bind community species in intricate ecological networks, preserving species that would otherwise be lost. The traditional understanding of ecological networks as static components of biological communities overlooks the fact that species interactions in a network can fluctuate. Analyzing the patterns that cause those shifts can reveal the principles that govern the identity of pairwise interactions and whether they are predictable based on the traits of the interacting species and the local environmental contexts in which they occur. Here we explore how abiotic stress and phylogenetic and functional affinities constrain those shifts. Specifically, we hypothesize that rewiring the facilitative interactions is more limited in stressful than in mild environments. We present evidence of a distinct pattern in the rewiring of facilitation-driven communities at different stress levels. In highly stressful environments with a firm reliance on facilitation, rewiring is limited to growing beneath nurse species with traits to overcome harsh stressful conditions. However, when environments are milder, rewiring is more flexible, although it is still constrained to nurses that are close relatives. Understanding the ability of species to rewire their interactions is crucial for predicting how communities may respond to the unprecedented rate of perturbations on Earth.

Effects and experience with the Mézières method in people with low back pain: A mixed methods study.

BACKGROUND: Low back pain (LBP) is one of the most common reasons for visiting the doctor. The Mézières method (MM) emphasises body awareness and uses a global postural rehabilitation approach. It is used in the management of LBP, but its effectiveness has received limited formal evaluation. OBJECTIVE: To determine the effects of MM on quality of life, pain and functional disability in people with LBP and understand the patient's bodily experience during the MM intervention. METHODS: This protocol study of single-blind randomised controlled trial with a mixed methods design will include 54 people with LBP aged 18 to 65 years. Participants will be randomised into two groups, one will receive MM and the other will receive a control intervention, administered through 10 treatment sessions. Participants will also construct a narrative to provide an understanding of their bodily experience. RESULTS: The assessed outcomes will include pain, back pain-related disability assessed using the Roland Morris Questionnaire, and quality of life related to health assessed using the SF12. Outcomes will be assessed at baseline, after the intervention and at a 6 weeks follow-up.

Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA).

BACKGROUND: There are two products in which infliximab is the active pharmaceutical ingredient. These are Remicade® (INF; reference product) and Remsima™/Inflectra™ (CT-P13; infliximab biosimilar). Remsima™/Inflectra™ are bioidentical products. Different recommendations have been made for the clinical solutions of each brand (Remicade® or Remsima™/Inflectra™) despite the manufacturer of the biosimilar claiming high levels of similarity to the innovator. OBJECTIVE: The objective of this study was to assess and compare stability against degradation and over time of different clinical infliximab solutions prepared from Remicade® and from Remsima™/Inflectra™ using a suitable set of characterization methods in line with the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) recommendations. METHODS: Reconstituted solutions of INF and CT-P13 and dilutions as used in hospital were stored in glass vials (10 and 2 mg/mL) or in polyolefin infusion bags (0.4 mg/mL) refrigerated between 2 and 8 °C for 2 weeks. Regarding the physicochemical properties, the distribution of the particulates were studied over a range of 0.001-1 µm by dynamic light scattering (DLS) and oligomers up to 8 monomer were analyzed by native size-exclusion ultra-high-performance liquid chromatography with ultraviolet (UV)-visible detection coupled to (native) mass spectrometry (SE/UHPLC-UV-(native) MS); mass spectrometry was also used to evaluate natural aggregates and isoform profile; DLS was also employed to detect gross conformational changes by tracking the hydrodynamic radius (HR). The secondary structure of the proteins was studied by far UV circular dichroism (CD). The tertiary structure was investigated by intrinsic tryptophan fluorescence (IT-F). Reverse-phase ultra-high-performance liquid chromatography with UV detection (RP/UHPLC-UV) was used to analyze intact INF and CT-P13 for quantification purposes. Functionality was evaluated via the biological activity measured by the extension of the immunological reaction of the INF and the CT-P13 with its antigen, i.e., the tumor necrosis factor-α by enzyme-linked immunosorbent assay (ELISA). RESULTS: The stress applied to INF and CT-P13 solutions showed similar levels of aggregate formation, structural variation, and chemical modifications. The only noteworthy difference between INF and CT-P13 was detected in their behavior to freeze-thaw cycles, in which CT-P13 showed slightly more robustness. INF and CT-P13 showed identical CD spectra, similar to those reported for IgG1 in which there is dominance in ß sheet secondary structures; this typical conformation remained unmodified over time in INF and CT-P13. No significant changes were detected in the tertiary structure and no aggregates process was noticed over the time studied. Polydispersity slightly increased for the most concentrated solutions, while there were no meaningful differences in the HR in the solutions over time. The concentration of INF and CT-P13 also remained constant. Differences in the native isoform MS profile were detected, as expected by the different glycosylation pattern, with no important modification over time. Functionality was maintained over the test period (60 days) and was similar in all the solutions tested, with no differences between INF and biosimilar solutions. CONCLUSIONS: High levels of similarity were noticed in the behavior of INF and CT-P13 when subjected to stress. When stored refrigerated at between 2 and 8 °C and prepared as normally used in the hospital pharmacy, all solutions showed physicochemical and functional stability for all the concentrations tested and all containers, at least for the 14-day test period.